↓ Skip to main content

Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada

Overview of attention for article published in Cost Effectiveness and Resource Allocation, June 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)

Mentioned by

blogs
1 blog
policy
1 policy source

Readers on

mendeley
67 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada
Published in
Cost Effectiveness and Resource Allocation, June 2010
DOI 10.1186/1478-7547-8-14
Pubmed ID
Authors

Gord Blackhouse, Kathryn Gaebel, Feng Xie, Kaitryn Campbell, Nazila Assasi, Jean-Eric Tarride, Daria O'Reilly, Colin Chalk, Mitchell Levine, Ron Goeree

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Spain 1 1%
Belgium 1 1%
Unknown 64 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 11 16%
Other 8 12%
Student > Ph. D. Student 8 12%
Student > Master 8 12%
Student > Bachelor 5 7%
Other 14 21%
Unknown 13 19%
Readers by discipline Count As %
Medicine and Dentistry 26 39%
Pharmacology, Toxicology and Pharmaceutical Science 6 9%
Neuroscience 5 7%
Agricultural and Biological Sciences 5 7%
Nursing and Health Professions 3 4%
Other 8 12%
Unknown 14 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 August 2023.
All research outputs
#4,215,606
of 25,373,627 outputs
Outputs from Cost Effectiveness and Resource Allocation
#102
of 533 outputs
Outputs of similar age
#17,362
of 103,848 outputs
Outputs of similar age from Cost Effectiveness and Resource Allocation
#1
of 3 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 533 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.9. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 103,848 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them